Jazz Pharmaceuticals plc
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Jazz Pharmaceuticals plc
Deal Snapshot: In acquiring its fellow San Diego firm for an estimated deal value of up to $516m, Ligand picks up protein-expression technology, revenue-driving partnerships and the potential for more.
New York biotech is partnering with researchers at Columbia, Kansas State and Southern Research to address the pandemic.
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
Given the consecutive growth Krka has seen in its prescription pharmaceuticals portfolio along with an increase in overall sales, the company has announced investments of €134m in infrastructure and production facilities. This follows a €30m investment in the first half of 2020.
- Contract Manufacturing Organization
- Drug Discovery Tools
- Other Names / Subsidiaries
- Alizé Pharma II
- Azur Pharma Public Limited Company
- Cavion, Inc.
- Cavion LLC (Tau Therapeutics LLC
- Xdynia LLC)
- Celator Pharmaceuticals, Inc.
- EUSA Pharma Inc. (Cytogen Corporation
- OPi SA)
- Gentium S.p.A.
- Jazz Pharmaceuticals Ireland Limited
- Orphan Medical, Inc.